CTLA4 and central nervous system cancer: In response to DC vaccines, an innovative therapeutic method for patients with glioma, the down-regulation of CTLA-4 on peripheral blood lymphocyte closely correlates with good prognosis in glioma patients, further supporting the significance of CTLA-4 in regulating anti-tumor immune responses [78].